The FDA issued a warning on infections associated with reprocessed flexible bronchoscopes.
Based on its preliminary investigation, the FDA said the risk of infection presented by reprocessed bronchoscopes appears to be lower than the risk of infection presented by reprocessed duodenoscopes.
Last year, reprocessed endoscopes caught the FDA’s attention due to numerous antibiotic-resistant infections reported. As a result, the agency issued final guidance in March 2015 strengthening controls on reprocessing ().
Noting recurrent issues, the agency said the same procedures for reprocessing should be applied to bronchoscopes: